立方体治疗:在肝细胞癌的免疫疗法潜在的辅助剂
Jiao Wang1, Chengyu Liu2, Ronghua Hu2
1Department of Laboratory Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in pharmacology
|February 16, 2024
概括
通过调节脂质代谢和免疫微环境,他类药物可以增强肝细胞癌 (HCC) 的免疫检查点抑制剂 (ICI) 治疗. 本综述探讨了他类药物作为高级HCC的潜在辅助疗法.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 癌症免疫学 癌症免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝细胞癌 (HCC) 是全球领先的癌症,通常呈现于晚期.
- 目前对晚期HCC的治疗方法,包括免疫检查点抑制剂 (ICI),单独显示出有限的疗效.
- 异常的脂质代谢和改变的免疫微环境是HCC的标志.
研究的目的:
- 在HCC中审查异常的脂质代谢.
- 总结关于在HCC中使用他类药物的临床证据.
- 探索他类药物作为HCC免疫疗法辅助疗法的潜力.
主要方法:
- 临床前和临床研究的文献综述.
- 在HCC中分析脂质代谢变化.
- 检查他类药物对免疫微环境和炎症反应的影响.
主要成果:
- 类药物通常被HCC患者使用,这些患者患有脂质失调症.
- 临床前和临床数据表明,他类药物可能会提高HCC的ICI疗效.
- 类药物可能调节炎症反应和瘤免疫微环境.
结论:
- 在HCC患者中,他类药物显示出除降低胆固醇之外的潜在益处.
- 类药物可能与ICI协同作用,以改善晚期HCC的治疗结果.
- 立方体治疗可能会成为HCC免疫疗法的宝贵辅助剂.
关键词:
在HCC中,HCC是HCC.ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI IC1 ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI IC1 IC1 IC1 IC1 IC1 IC2 IC2 IC1 IC2 IC2 IC1 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which胆固醇 胆固醇 胆固醇 是一种免疫疗法 免疫疗法这是一种炎症炎症炎症炎症.类药物 类药物 类药物相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
661
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


